{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:41:16Z","timestamp":1793472076643,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1038\/s41440-024-01731-6","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T09:01:42Z","timestamp":1716368502000},"page":"2115-2125","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Immunological insights into hypertension: unraveling triggers and potential therapeutic avenues"],"prefix":"10.1038","volume":"47","author":[{"given":"Brandon G.","family":"Shokoples","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Paradis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto L.","family":"Schiffrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,22]]},"reference":[{"key":"1731_CR1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","volume":"134","author":"KT Mills","year":"2016","unstructured":"Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134:441\u201350.","journal-title":"Circulation"},{"key":"1731_CR2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cjca.2020.02.083","volume":"36","author":"S Hiremath","year":"2020","unstructured":"Hiremath S, Sapir-Pichhadze R, Nakhla M, Gabor JY, Khan NA, Kuyper LM, et al. Hypertension Canada\u2019s 2020 evidence review and guidelines for the management of resistant hypertension. Can J Cardiol. 2020;36:625\u201334.","journal-title":"Can J Cardiol"},{"key":"1731_CR3","unstructured":"Okuda T, Grollman A. Passive transfer of autoimmune induced hypertension in the rat by lymph node cells. Tex Rep Biol Med. 1967;25:257\u201364."},{"key":"1731_CR4","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1111\/bph.14427","volume":"176","author":"A Caillon","year":"2019","unstructured":"Caillon A, Paradis P, Schiffrin EL. Role of immune cells in hypertension. Br J Pharm. 2019;176:1818\u201328.","journal-title":"Br J Pharm"},{"key":"1731_CR5","doi-asserted-by":"publisher","unstructured":"Guzik TJ, Nosalski R, Maffia P, Drummond GR. Immune and inflammatory mechanisms in hypertension. Nat Rev Cardiol. 2024. https:\/\/doi.org\/10.1038\/s41569-023-00964-1.","DOI":"10.1038\/s41569-023-00964-1"},{"key":"1731_CR6","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cjca.2020.02.086","volume":"36","author":"DM Rabi","year":"2020","unstructured":"Rabi DM, McBrien KA, Sapir-Pichhadze R, Nakhla M, Ahmed SB, Dumanski SM, et al. Hypertension Canada\u2019s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children. Can J Cardiol. 2020;36:596\u2013624.","journal-title":"Can J Cardiol"},{"key":"1731_CR7","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 international society of hypertension global hypertension practice guidelines. Hypertension. 2020;75:1334\u201357.","journal-title":"Hypertension"},{"key":"1731_CR8","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstrom M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41:1874\u20132071.","journal-title":"J Hypertens"},{"key":"1731_CR9","first-page":"e13","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018;71:e13\u2013e115.","journal-title":"Hypertension"},{"key":"1731_CR10","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42:1235\u2013481.","journal-title":"Hypertens Res"},{"key":"1731_CR11","doi-asserted-by":"crossref","DOI":"10.1038\/srep28990","volume":"6","author":"M Gulhane","year":"2016","unstructured":"Gulhane M, Murray L, Lourie R, Tong H, Sheng YH, Wang R, et al. High fat diets induce colonic epithelial cell stress and inflammation that is reversed by IL-22. Sci Rep. 2016;6:28990.","journal-title":"Sci Rep"},{"key":"1731_CR12","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1073\/pnas.1814273116","volume":"116","author":"BA Napier","year":"2019","unstructured":"Napier BA, Andres-Terre M, Massis LM, Hryckowian AJ, Higginbottom SK, Cumnock K, et al. Western diet regulates immune status and the response to LPS-driven sepsis independent of diet-associated microbiome. Proc Natl Acad Sci USA. 2019;116:3688\u201394.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1731_CR13","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/cvr\/cvaa207","volume":"117","author":"N Ruggeri Barbaro","year":"2021","unstructured":"Ruggeri Barbaro N, Van Beusecum J, Xiao L, do Carmo L, Pitzer A, Loperena R, et al. Sodium activates human monocytes via the NADPH oxidase and isolevuglandin formation. Cardiovasc Res. 2021;117:1358\u201371.","journal-title":"Cardiovasc Res"},{"key":"1731_CR14","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","volume":"20","author":"N Kelley","year":"2019","unstructured":"Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019;20:3328.","journal-title":"Int J Mol Sci"},{"key":"1731_CR15","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.4049\/jimmunol.173.6.3589","volume":"173","author":"HS Park","year":"2004","unstructured":"Park HS, Jung HY, Park EY, Kim J, Lee WJ, Bae YS. Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J Immunol. 2004;173:3589\u201393.","journal-title":"J Immunol"},{"key":"1731_CR16","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/CIRCRESAHA.121.318063","volume":"128","author":"KK Griendling","year":"2021","unstructured":"Griendling KK, Camargo LL, Rios FJ, Alves-Lopes R, Montezano AC, Touyz RM. Oxidative stress and hypertension. Circ Res. 2021;128:993\u20131020.","journal-title":"Circ Res"},{"key":"1731_CR17","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3389\/fphys.2019.00655","volume":"10","author":"KP Nunes","year":"2019","unstructured":"Nunes KP, de Oliveira AA, Lima VV, Webb RC. Toll-Like receptor 4 and blood pressure: lessons from animal studies. Front Physiol. 2019;10:655.","journal-title":"Front Physiol"},{"key":"1731_CR18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1042\/CS20180087","volume":"132","author":"S Kim","year":"2018","unstructured":"Kim S, Goel R, Kumar A, Qi Y, Lobaton G, Hosaka K, et al. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure. Clin Sci. 2018;132:701\u201318.","journal-title":"Clin Sci"},{"key":"1731_CR19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41371-020-00407-1","volume":"35","author":"O Balafa","year":"2021","unstructured":"Balafa O, Kalaitzidis RG. Salt sensitivity and hypertension. J Hum Hypertens. 2021;35:184\u201392.","journal-title":"J Hum Hypertens"},{"key":"1731_CR20","doi-asserted-by":"publisher","unstructured":"Bailey MA, Dhaun N. Salt sensitivity: causes, consequences, and recent advances. Hypertension. 2023. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.123.17959.","DOI":"10.1161\/HYPERTENSIONAHA.123.17959"},{"key":"1731_CR21","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92801","volume":"2","author":"AE Norlander","year":"2017","unstructured":"Norlander AE, Saleh MA, Pandey AK, Itani HA, Wu J, Xiao L, et al. A salt-sensing kinase in T lymphocytes, SGK1, drives hypertension and hypertensive end-organ damage. JCI Insight. 2017;2:e92801.","journal-title":"JCI Insight"},{"key":"1731_CR22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/HYPERTENSIONAHA.119.12761","volume":"74","author":"JP Van Beusecum","year":"2019","unstructured":"Van Beusecum JP, Barbaro NR, McDowell Z, Aden LA, Xiao L, Pandey AK, et al. High salt activates CD11c(+) antigen-presenting cells via SGK (serum glucocorticoid kinase) 1 to promote renal inflammation and salt-sensitive hypertension. Hypertension. 2019;74:555\u201363.","journal-title":"Hypertension"},{"key":"1731_CR23","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.celrep.2017.10.002","volume":"21","author":"NR Barbaro","year":"2017","unstructured":"Barbaro NR, Foss JD, Kryshtal DO, Tsyba N, Kumaresan S, Xiao L, et al. Dendritic cell amiloride-sensitive channels mediate sodium-induced inflammation and hypertension. Cell Rep. 2017;21:1009\u201320.","journal-title":"Cell Rep"},{"key":"1731_CR24","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1172\/JCI74084","volume":"124","author":"A Kirabo","year":"2014","unstructured":"Kirabo A, Fontana V, de Faria AP, Loperena R, Galindo CL, Wu J, et al. DC isoketal-modified proteins activate T cells and promote hypertension. J Clin Investig. 2014;124:4642\u201356.","journal-title":"J Clin Investig"},{"key":"1731_CR25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/CIRCRESAHA.122.320818","volume":"131","author":"A Pitzer","year":"2022","unstructured":"Pitzer A, Elijovich F, Laffer CL, Ertuglu LA, Sahinoz M, Saleem M, et al. DC ENaC-dependent inflammasome activation contributes to salt-sensitive hypertension. Circ Res. 2022;131:328\u201344.","journal-title":"Circ Res"},{"key":"1731_CR26","first-page":"414","volume":"10","author":"S Jang","year":"2023","unstructured":"Jang S, Kim JY, Kim CW, Kim I. Hypertonic salt solution enhances inflammatory responses in cultured splenic T-cells from Dahl salt-sensitive rats but not Dahl salt-resistant rats. J Cardiovasc Dev Dis. 2023;10:414.","journal-title":"J Cardiovasc Dev Dis"},{"key":"1731_CR27","doi-asserted-by":"publisher","unstructured":"Ertuglu LA, Pitzer Mutchler A, Jamison S, Laffer CL, Elijovich F, Saleem M, et al. Eicosanoid-regulated myeloid ENaC and isolevuglandin formation in human salt-sensitive hypertension. Hypertension. 2023. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.123.21285.","DOI":"10.1161\/HYPERTENSIONAHA.123.21285"},{"key":"1731_CR28","doi-asserted-by":"crossref","first-page":"e006658","DOI":"10.1161\/JAHA.117.006658","volume":"6","author":"O Palygin","year":"2017","unstructured":"Palygin O, Evans LC, Cowley AW Jr, Staruschenko A. Acute in vivo analysis of ATP release in rat kidneys in response to changes of renal perfusion pressure. J Am Heart Assoc. 2017;6:e006658.","journal-title":"J Am Heart Assoc"},{"key":"1731_CR29","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0006-291X(90)92141-L","volume":"170","author":"P Milner","year":"1990","unstructured":"Milner P, Bodin P, Loesch A, Burnstock G. Rapid release of endothelin and ATP from isolated aortic endothelial cells exposed to increased flow. Biochem Biophys Res Commun. 1990;170:649\u201356.","journal-title":"Biochem Biophys Res Commun"},{"key":"1731_CR30","doi-asserted-by":"crossref","first-page":"eaau6426","DOI":"10.1126\/sciimmunol.aau6426","volume":"4","author":"TV Zhao","year":"2019","unstructured":"Zhao TV, Li Y, Liu X, Xia S, Shi P, Li L, et al. ATP release drives heightened immune responses associated with hypertension. Sci Immunol. 2019;4:eaau6426.","journal-title":"Sci Immunol"},{"key":"1731_CR31","doi-asserted-by":"crossref","first-page":"F161","DOI":"10.1152\/ajprenal.00281.2007","volume":"294","author":"ML Graciano","year":"2008","unstructured":"Graciano ML, Nishiyama A, Jackson K, Seth DM, Ortiz RM, Prieto-Carrasquero MC, et al. Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension. Am J Physiol Ren Physiol. 2008;294:F161\u20139.","journal-title":"Am J Physiol Ren Physiol"},{"key":"1731_CR32","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1097\/HJH.0000000000003520","volume":"41","author":"BG Shokoples","year":"2023","unstructured":"Shokoples BG, Berillo O, Comeau K, Chen HY, Higaki A, Caillon A, et al. P2RX7 gene knockout or antagonism reduces angiotensin II-induced hypertension, vascular injury and immune cell activation. J Hypertens. 2023;41:1701\u201312.","journal-title":"J Hypertens"},{"key":"1731_CR33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/ATVBAHA.120.315116","volume":"41","author":"BG Shokoples","year":"2021","unstructured":"Shokoples BG, Paradis P, Schiffrin EL. P2X7 receptors: an untapped target for the management of cardiovascular disease. Arterioscler Thromb Vasc Biol. 2021;41:186\u201399.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1731_CR34","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/CIRCRESAHA.121.319643","volume":"129","author":"JP Van Beusecum","year":"2021","unstructured":"Van Beusecum JP, Barbaro NR, Smart CD, Patrick DM, Loperena R, Zhao S, et al. Growth arrest specific-6 and Axl coordinate inflammation and hypertension. Circ Res. 2021;129:975\u201391.","journal-title":"Circ Res"},{"key":"1731_CR35","doi-asserted-by":"crossref","first-page":"e0151060","DOI":"10.1371\/journal.pone.0151060","volume":"11","author":"K Srivastava","year":"2016","unstructured":"Srivastava K, Narang R, Bhatia J, Saluja D. Expression of heat shock protein 70 gene and its correlation with inflammatory markers in essential hypertension. PLoS ONE. 2016;11:e0151060.","journal-title":"PLoS ONE"},{"key":"1731_CR36","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.CIR.92.5.1223","volume":"92","author":"Q Xu","year":"1995","unstructured":"Xu Q, Li DG, Holbrook NJ, Udelsman R. Acute hypertension induces heat-shock protein 70 gene expression in rat aorta. Circulation. 1995;92:1223\u20139.","journal-title":"Circulation"},{"key":"1731_CR37","doi-asserted-by":"publisher","unstructured":"Bravo J, Quiroz Y, Pons H, Parra G, Herrera-Acosta J, Johnson RJ, et al. Vimentin and heat shock protein expression are induced in the kidney by angiotensin and by nitric oxide inhibition. Kidney Int Suppl. 2003. https:\/\/doi.org\/10.1046\/j.1523-1755.64.s86.9.x)(86):S46-51.","DOI":"10.1046\/j.1523-1755.64.s86.9.x)(86):S46-51"},{"key":"1731_CR38","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1038\/ki.2008.513","volume":"74","author":"G Parra","year":"2008","unstructured":"Parra G, Quiroz Y, Salazar J, Bravo Y, Pons H, Chavez M, et al. Experimental induction of salt-sensitive hypertension is associated with lymphocyte proliferative response to HSP70. Kidney Int Suppl. 2008;74:S55\u201359.","journal-title":"Kidney Int Suppl"},{"key":"1731_CR39","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/bph.14334","volume":"176","author":"B Rodriguez-Iturbe","year":"2019","unstructured":"Rodriguez-Iturbe B, Lanaspa MA, Johnson RJ. The role of autoimmune reactivity induced by heat shock protein 70 in the pathogenesis of essential hypertension. Br J Pharm. 2019;176:1829\u201338.","journal-title":"Br J Pharm"},{"key":"1731_CR40","doi-asserted-by":"crossref","first-page":"F289","DOI":"10.1152\/ajprenal.00517.2012","volume":"304","author":"H Pons","year":"2013","unstructured":"Pons H, Ferrebuz A, Quiroz Y, Romero-Vasquez F, Parra G, Johnson RJ, et al. Immune reactivity to heat shock protein 70 expressed in the kidney is cause of salt-sensitive hypertension. Am J Physiol Ren Physiol. 2013;304:F289\u2013299.","journal-title":"Am J Physiol Ren Physiol"},{"key":"1731_CR41","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1097\/00004872-200209000-00027","volume":"20","author":"AG Pockley","year":"2002","unstructured":"Pockley AG, De Faire U, Kiessling R, Lemne C, Thulin T, Frostegard J. Circulating heat shock protein and heat shock protein antibody levels in established hypertension. J Hypertens. 2002;20:1815\u201320.","journal-title":"J Hypertens"},{"key":"1731_CR42","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104217","volume":"357","author":"K Comeau","year":"2020","unstructured":"Comeau K, Paradis P, Schiffrin EL. Human and murine memory \u03b3\u03b4 T cells: evidence for acquired immune memory in bacterial and viral infections and autoimmunity. Cell Immunol. 2020;357:104217.","journal-title":"Cell Immunol"},{"key":"1731_CR43","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1161\/CIRCULATIONAHA.116.027058","volume":"135","author":"A Caillon","year":"2017","unstructured":"Caillon A, Mian MOR, Fraulob-Aquino JC, Huo KG, Barhoumi T, Ouerd S, et al. \u03b3\u03b4 T cells mediate angiotensin II-induced hypertension and vascular injury. Circulation. 2017;135:2155\u201362.","journal-title":"Circulation"},{"key":"1731_CR44","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12872-021-01857-2","volume":"21","author":"JAC Delaney","year":"2021","unstructured":"Delaney JAC, Olson NC, Sitlani CM, Fohner AE, Huber SA, Landay AL, et al. Natural killer cells, gamma delta T cells and classical monocytes are associated with systolic blood pressure in the multi-ethnic study of atherosclerosis (MESA). BMC Cardiovasc Disord. 2021;21:45.","journal-title":"BMC Cardiovasc Disord"},{"key":"1731_CR45","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.3389\/fimmu.2018.02636","volume":"9","author":"C Khairallah","year":"2018","unstructured":"Khairallah C, Chu TH, Sheridan BS. Tissue adaptations of memory and tissue-resident gamma delta T cells. Front Immunol. 2018;9:2636.","journal-title":"Front Immunol"},{"key":"1731_CR46","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41440-022-01055-3","volume":"46","author":"BG Shokoples","year":"2023","unstructured":"Shokoples BG, Comeau K, Higaki A, Ferreira NS, Caillon A, Berillo O, et al. Angiotensin II-induced a steeper blood pressure elevation in IL-23 receptor-deficient mice: role of interferon-gamma-producing T cells. Hypertens Res. 2023;46:40\u201349.","journal-title":"Hypertens Res"},{"key":"1731_CR47","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/CIRCRESAHA.115.308111","volume":"118","author":"HA Itani","year":"2016","unstructured":"Itani HA, Xiao L, Saleh MA, Wu J, Pilkinton MA, Dale BL, et al. CD70 exacerbates blood pressure elevation and renal damage in response to repeated hypertensive stimuli. Circ Res. 2016;118:1233\u201343.","journal-title":"Circ Res"},{"key":"1731_CR48","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/ajh\/hpad072","volume":"36","author":"K Comeau","year":"2023","unstructured":"Comeau K, Shokoples B, Caillon A, Paradis P, Schiffrin EL. Angiotensin II-induced memory \u03b3\u03b4 T cells sensitize mice to a mild hypertensive stimulus. Am J Hypertens. 2023;36:619\u201328.","journal-title":"Am J Hypertens"},{"key":"1731_CR49","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1161\/HYPERTENSIONAHA.123.21112","volume":"80","author":"X Ma","year":"2023","unstructured":"Ma X, Zhuo Y, Huang Y, He P, Huang Z, Jiang L, et al. Reduced diversities and clonally expanded sequences of T-cell receptors in patients with essential hypertension and subclinical carotid atherosclerosis. Hypertension. 2023;80:2318\u201329.","journal-title":"Hypertension"},{"key":"1731_CR50","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/HYPERTENSIONAHA.116.07237","volume":"68","author":"HA Itani","year":"2016","unstructured":"Itani HA, McMaster WG Jr, Saleh MA, Nazarewicz RR, Mikolajczyk TP, Kaszuba AM, et al. Activation of human T cells in hypertension: studies of humanized mice and hypertensive humans. Hypertension 2016;68:123\u201332.","journal-title":"Hypertension"},{"key":"1731_CR51","doi-asserted-by":"crossref","first-page":"1132040","DOI":"10.3389\/fcell.2023.1132040","volume":"11","author":"X Wang","year":"2023","unstructured":"Wang X, Wu X, Zhang P, Zhou Y, Cai J, Jin L. Single-cell transcriptome profiling reveals enriched memory T-cell subpopulations in hypertension. Front Cell Dev Biol. 2023;11:1132040.","journal-title":"Front Cell Dev Biol"},{"key":"1731_CR52","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1080\/10641963.2018.1523914","volume":"41","author":"C Gong","year":"2019","unstructured":"Gong C, Liu X, Ding L, Liu Y, Li T, Wang S, et al. A non-synonymous polymorphism in purinergic P2X7 receptor gene confers reduced susceptibility to essential hypertension in Chinese postmenopausal women. Clin Exp Hypertens. 2019;41:558\u201363.","journal-title":"Clin Exp Hypertens"},{"key":"1731_CR53","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1161\/HYPERTENSIONAHA.108.113282","volume":"52","author":"J Palomino-Doza","year":"2008","unstructured":"Palomino-Doza J, Rahman TJ, Avery PJ, Mayosi BM, Farrall M, Watkins H, et al. Ambulatory blood pressure is associated with polymorphic variation in P2X receptor genes. Hypertension. 2008;52:980\u20135.","journal-title":"Hypertension"},{"key":"1731_CR54","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/sj.ejhg.5201698","volume":"14","author":"T Omi","year":"2006","unstructured":"Omi T, Kumada M, Kamesaki T, Okuda H, Munkhtulga L, Yanagisawa Y, et al. An intronic variable number of tandem repeat polymorphisms of the cold-induced autoinflammatory syndrome 1 (CIAS1) gene modifies gene expression and is associated with essential hypertension. Eur J Hum Genet. 2006;14:1295\u2013305.","journal-title":"Eur J Hum Genet"},{"key":"1731_CR55","doi-asserted-by":"crossref","first-page":"144838","DOI":"10.1016\/j.gene.2020.144838","volume":"754","author":"B Pineda","year":"2020","unstructured":"Pineda B, Pertusa C, Panach L, Tarin JJ, Cano A, Garcia-Perez MA. Polymorphisms in genes involved in T-cell co-stimulation are associated with blood pressure in women. Gene. 2020;754:144838.","journal-title":"Gene"},{"key":"1731_CR56","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.jacc.2021.02.009","volume":"77","author":"MS Garshick","year":"2021","unstructured":"Garshick MS, Ward NL, Krueger JG, Berger JS. Cardiovascular risk in patients with psoriasis: JACC review topic of the week. J Am Coll Cardiol. 2021;77:1670\u201380.","journal-title":"J Am Coll Cardiol"},{"key":"1731_CR57","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/rheumatology\/kem169","volume":"46","author":"VF Panoulas","year":"2007","unstructured":"Panoulas VF, Douglas KM, Milionis HJ, Stavropoulos-Kalinglou A, Nightingale P, Kita MD, et al. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatol. 2007;46:1477\u201382.","journal-title":"Rheumatol"},{"key":"1731_CR58","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11906-019-0914-2","volume":"21","author":"VL Wolf","year":"2019","unstructured":"Wolf VL, Ryan MJ. Autoimmune disease-associated hypertension. Curr Hypertens Rep. 2019;21:10.","journal-title":"Curr Hypertens Rep"},{"key":"1731_CR59","doi-asserted-by":"crossref","first-page":"S218","DOI":"10.1681\/ASN.2006080918","volume":"17","author":"J Herrera","year":"2006","unstructured":"Herrera J, Ferrebuz A, MacGregor EG, Rodriguez-Iturbe B. Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis. J Am Soc Nephrol. 2006;17:S218\u2013225.","journal-title":"J Am Soc Nephrol"},{"key":"1731_CR60","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41371-022-00682-0","volume":"37","author":"JS Clemmer","year":"2023","unstructured":"Clemmer JS, Hillegass WB, Taylor EB. Antihypertensive effects of immunosuppressive therapy in autoimmune disease. J Hum Hypertens. 2023;37:300\u20136.","journal-title":"J Hum Hypertens"},{"key":"1731_CR61","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1759720X17719850","volume":"9","author":"AA Mangoni","year":"2017","unstructured":"Mangoni AA, Baghdadi LR, Shanahan EM, Wiese MD, Tommasi S, Elliot D, et al. Methotrexate, blood pressure and markers of arterial function in patients with rheumatoid arthritis: a repeated cross-sectional study. Ther Adv Musculoskelet Dis. 2017;9:213\u201329.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"1731_CR62","first-page":"e46","volume":"80","author":"JB Cohen","year":"2023","unstructured":"Cohen JB, Brown NJ, Brown SA, Dent S, van Dorst DCH, Herrmann SM, et al. Cancer therapy-related hypertension: a scientific statement from the American Heart Association. Hypertension. 2023;80:e46\u2013e57.","journal-title":"Hypertension"},{"key":"1731_CR63","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1161\/HYPERTENSIONAHA.122.19865","volume":"79","author":"S Minegishi","year":"2022","unstructured":"Minegishi S, Kinguchi S, Horita N, Namkoong H, Briasoulis A, Ishigami T, et al. Immune checkpoint inhibitors do not increase short-term risk of hypertension in cancer patients: a systematic literature review and meta-analysis. Hypertension. 2022;79:2611\u201321.","journal-title":"Hypertension"},{"key":"1731_CR64","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41392-023-01577-3","volume":"8","author":"Y Qiu","year":"2023","unstructured":"Qiu Y, Xu S, Chen X, Wu X, Zhou Z, Zhang J, et al. NAD(+) exhaustion by CD38 upregulation contributes to blood pressure elevation and vascular damage in hypertension. Signal Transduct Target Ther. 2023;8:353.","journal-title":"Signal Transduct Target Ther"},{"key":"1731_CR65","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3390\/ijms19041126","volume":"19","author":"SD Hiller","year":"2018","unstructured":"Hiller SD, Heldmann S, Richter K, Jurastow I, Kullmar M, Hecker A, et al. \u03b2-nicotinamide adenine dinucleotide (\u03b2-NAD) inhibits ATP-dependent IL-1\u03b2 release from human monocytic cells. Int J Mol Sci. 2018;19:1126.","journal-title":"Int J Mol Sci"},{"key":"1731_CR66","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl J Med. 2017;377:1119\u201331.","journal-title":"N. Engl J Med"},{"key":"1731_CR67","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/HYPERTENSIONAHA.119.13642","volume":"75","author":"AM Rothman","year":"2020","unstructured":"Rothman AM, MacFadyen J, Thuren T, Webb A, Harrison DG, Guzik TJ, et al. Effects of interleukin-1\u03b2 inhibition on blood pressure, incident hypertension, and residual inflammatory risk: a secondary analysis of CANTOS. Hypertension. 2020;75:477\u201382.","journal-title":"Hypertension"},{"key":"1731_CR68","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.3390\/ijms23031772","volume":"23","author":"P Bryniarski","year":"2022","unstructured":"Bryniarski P, Nazimek K, Marcinkiewicz J. Immunomodulatory activity of the most commonly used antihypertensive drugs-angiotensin converting enzyme inhibitors and angiotensin II receptor blockers. Int J Mol Sci. 2022;23:1772.","journal-title":"Int J Mol Sci"},{"key":"1731_CR69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ajh\/hpaa137","volume":"34","author":"NS Ferreira","year":"2021","unstructured":"Ferreira NS, Tostes RC, Paradis P, Schiffrin EL. Aldosterone, inflammation, immune system, and hypertension. Am J Hypertens. 2021;34:15\u201327.","journal-title":"Am J Hypertens"},{"key":"1731_CR70","volume":"11","author":"SR Kim","year":"2020","unstructured":"Kim SR, Lee SG, Kim SH, Kim JH, Choi E, Cho W, et al. SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease. Nat Commun. 2020;11:2127.","journal-title":"Nat Commun"},{"key":"1731_CR71","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13098-023-01092-z","volume":"15","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Zhou S, Liu L. Efficacy and safety evaluation of SGLT2i on blood pressure control in patients with type 2 diabetes and hypertension: a new meta-analysis. Diabetol Metab Syndr. 2023;15:118.","journal-title":"Diabetol Metab Syndr"},{"key":"1731_CR72","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jchf.2022.09.002","volume":"11","author":"S Selvaraj","year":"2023","unstructured":"Selvaraj S, Vaduganathan M, Claggett BL, Miao ZM, Fang JC, Vardeny O, et al. Blood pressure and dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: DELIVER. JACC Heart Fail 2023;11:76\u201389.","journal-title":"JACC Heart Fail"},{"key":"1731_CR73","first-page":"61","volume":"145","author":"SG Deftereos","year":"2022","unstructured":"Deftereos SG, Beerkens FJ, Shah B, Giannopoulos G, Vrachatis DA, Giotaki SG, et al. Colchicine in cardiovascular disease: in-depth review. Circulation. 2022;145:61\u201378.","journal-title":"Circulation"},{"key":"1731_CR74","first-page":"221","volume":"3","author":"G Lagrue","year":"1985","unstructured":"Lagrue G, Wegrowski J, Rhabar K, Meyer-Heine A, Balanger S, Robert AM, et al. Effect of colchicine on atherosclerosis. I. Clinical and biological studies. Clin Physiol Biochem. 1985;3:221\u20135.","journal-title":"Clin Physiol Biochem"},{"key":"1731_CR75","unstructured":"ClinicalTrials.gov. The COlchicine HypERtENsion Trial (COHERENT). https:\/\/clinicaltrials.gov\/study\/NCT04916522. Accessed 25 March 2024."}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01731-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01731-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01731-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T23:07:09Z","timestamp":1722812829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01731-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,22]]},"references-count":75,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1731"],"URL":"https:\/\/doi.org\/10.1038\/s41440-024-01731-6","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,22]]},"assertion":[{"value":"27 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}